INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 1982

Amygdalin and metabolic therapy showed no cancer benefits and presented cyanide toxicity risks

One hundred seventy-eight cancer patients received amygdalin alongside a metabolic regimen of diet, enzymes, and vitamins. The treatment produced no measurable cure, tumor stabilization, symptom relief, or prolonged survival. Several participants experienced manifestations of cyanide toxicity, with blood cyanide concentrations nearing fatal thresholds.

Study type
Uncontrolled clinical trial
Who was studied
178 patients with cancer
What was measured
Cancer progression, symptom relief, survival, and cyanide toxicity

THE PAPER

A clinical trial of amygdalin (Laetrile) in the treatment of human cancer.

Moertel CG, Fleming TR, Rubin J, Kvols LK, Sarna G, Koch R, Currie VE, Young CW, Jones SE, Davignon JP. N Engl J Med, 1982.

PubMed 7033783 ↗DOI 10.1056/NEJM198201283060403 ↗

CancerFood safety & contaminants

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.